Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
7.27
-0.19 (-2.55%)
At close: Apr 1, 2025, 4:00 PM
7.21
-0.06 (-0.83%)
After-hours: Apr 1, 2025, 7:49 PM EDT

Anbio Biotechnology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21
Net Income
4.332.2510.012.54
Depreciation & Amortization
00.010.01-
Loss (Gain) From Sale of Investments
-0.29-0.16-0.04-
Change in Accounts Receivable
-4.62-1.880.72-0.72
Change in Inventory
-0.35-0.35-
Change in Accounts Payable
-0.83-0.58-0.481.89
Change in Other Net Operating Assets
0.760.91-5.410.47
Operating Cash Flow
-0.630.94.454.18
Operating Cash Flow Growth
--79.81%6.40%-
Investment in Securities
0.291.73-1.53-
Investing Cash Flow
0.291.73-1.53-
Other Financing Activities
0.1-0.04--
Financing Cash Flow
0.1-0.04--
Net Cash Flow
-0.252.592.924.18
Levered Free Cash Flow
-2.090.030.87-
Unlevered Free Cash Flow
-2.090.030.87-
Change in Net Working Capital
4.681.215.51-
Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q